Tag: biologics contract development market report

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

2024-2033 Biologics Contract Development Market Growth Rate: What’s the Forecast?

The biologics contract development market expanded rapidly, increasing from $6.94 billion in 2023 to $7.7 billion in 2024, at a CAGR of 11.0%. Growth drivers included the rise of biologics, biopharmaceuticals, patent expirations, complexity of development, and cost efficiency.

The biologics contract development market is expected to grow to $11.68 billion by 2028, expanding at a CAGR of 11.0%. The growth is attributed to digitalization, risk management, R&D investment, precision medicine, and personalized therapies. Trends include regenerative medicine, risk mitigation, global collaborations, advanced technologies, and technological integration.

Claim Your Free Sample of the Global Biologics Contract Development Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp

What Drivers Are Accelerating the Growth of the biologics contract development Market?

Similarly, the biologics contract development market anticipates significant growth, driven by the increasing prevalence of chronic diseases globally. Chronic illnesses, responsible for approximately 71% of global deaths according to April 2021 data from the World Health Organization, necessitate ongoing medical interventions, thus creating a demand for innovative biologic drugs. This rise in chronic diseases fuels the expansion of the biologics contract development market, mirroring its projected market sizes for 2023, 2024, and 2028.

What Key Segments Can Be Identified in the Biologics Contract Development Market?

1) By Source: Microbial, Mammalian, Others Soruces

2) By Indication: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Indications

3) By Product Service: Cell Line Development, Process Development, Others Product Services

What Trends Are On the Rise in the 112 Market?

Technological advancements are increasingly prominent in the biologics contract development market, with major companies integrating advanced technologies to maintain their market positions. For instance, in January 2022, Lonza, a Switzerland-based contract manufacturing and development solutions company, launched the bYlok technology platform. This platform facilitates the design and manufacture of bispecific antibodies, addressing issues such as light-heavy chain mispairing with high yields and accuracy. Accessible through a simple research license, it caters to the needs of pharma and biotech companies.

Order Now for Fast Delivery of Your Biologics Contract Development Market Report!

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

What Regions Are Steering Growth in the Biologics Contract Development Sector?

North America was the largest region in the biologics contract development market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Biologics Contract Development Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biologics contract development market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Biologics Contract Development Market Include

1. Biologics Contract Development Market Executive Summary

2. Biologics Contract Development Market Segments

3. Biologics Contract Development Market Size And Template Market Growth Rate

4. Key Biologics Contract Development Market Trends

5. Major Biologics Contract Development Market Drivers

……

25. Key Mergers And Acquisitions In The Biologics Contract Development Market

26. Top Biologics Contract Development Companies

27. Biologics Contract Development Market Opportunities And Strategies

28. Biologics Contract Development Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Chemicals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Ethylene Propylene Diene Monomer Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ethylene-propylene-diene-monomer-global-market-report

Genetically Modified Crops Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The biologics contract development market has witnessed rapid growth, with the market size reaching $6.94 billion in 2023 and projected to grow to $7.7 billion in 2024, showcasing a notable CAGR of 11.0%. Looking ahead, the forecast indicates continued expansion, reaching $11.68 billion by 2028 with a CAGR of 11.0%. Key drivers of historic growth include the rise in the biologics market, increased focus on biopharmaceuticals, the complexity of biologics, patent expirations, and cost efficiency.

Increasing Investment in Biopharmaceuticals

• Biopharmaceutical Demand: The growth of the biologics contract development market is fueled by the increasing demand for biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and gene therapies.
• Outsourcing Dynamics: Companies are outsourcing development activities to meet market demands, leading to substantial growth.
• Strategic Investment Example: FUJIFILM Corporation invested $2 billion in creating a new large-scale cell culture production site in the U.S. in January 2021, accelerating its biopharmaceutical contract development and manufacturing business.

Key Market Players

Major companies contributing to the biologics contract development market include WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, and many others. These companies play a pivotal role in advancing the capabilities and services within the market.

Innovative Technological Integration Elevates Market Dynamics

• Lonza’s BYlok Platform: Lonza, a Switzerland-based company, launched the bYlok technology platform in January 2022, setting a new standard for designing and manufacturing bispecific antibodies.
  • Key Features: Solves light-heavy chain mispairing issue, high yields (>95% accuracy), maintains a mAb-like format.
  • Accessibility: Pharma and biotech companies can access the platform through a simple research license.
• Recipharm’s Strategic Acquisition: In February 2022, Recipharm, a Sweden-based organization, strategically acquired Vibalogics and Arranta Bio.
  • Strategic Impact: Strengthens Recipharm’s presence in advanced therapy medicinal products and expands virotherapy manufacturing capabilities in the U.S.
  • Acquired Companies: Vibalogics (Germany) and Arranta Bio (U.S.) are contract development and manufacturing organizations.

Market Segmentation

The biologics contract development market is segmented based on:

1. Source: Microbial, Mammalian, Others Sources
2. Indication: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Indications
3. Product Service: Cell Line Development, Process Development, Others Product Services

Regional Trends

• North America Dominance: North America emerged as the largest region in the biologics contract development market in 2023.
• Asia-Pacific Growth: Asia-Pacific is expected to be the fastest-growing region in the forecast period.

View More On The Biologics Contract Development Market Report 2024 – https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Future Trends and Outlook

• Digitalization and Data Analytics: The forecast period will see rapid growth driven by digitalization, data analytics, and a focus on precision medicine and personalized therapies.
• Regenerative Medicine: A notable trend includes a focus on regenerative medicine, aligning with the growing demand for advanced therapeutic solutions.
• Risk Mitigation Strategies: Companies are adopting risk mitigation strategies to navigate the complexities associated with biologics development.
• Global Collaborations: Increasing global collaborations are expected to shape the market dynamics, fostering innovation and knowledge exchange.
• Technological Integration: Advanced technologies, including digital solutions and data analytics, will continue to be integrated to enhance biologics contract development capabilities.

Conclusion
The biologics contract development market’s significant growth is intricately linked to the increasing investment in biopharmaceuticals and the integration of innovative technologies by major players. As the market continues to evolve, digitalization, data analytics, and a focus on precision medicine will play pivotal roles in shaping the future of biologics contract development. With a strong market size and diverse trends, the biologics contract development market remains at the forefront of driving advancements in the biopharmaceutical industry.

Request A Sample Of The Global Biologics Contract Development Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=8219&type=smp